Fourth-generation fluoroquinolones in tuberculosis
- 1 April 2009
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 373 (9670), 1148-1149
- https://doi.org/10.1016/s0140-6736(09)60559-6
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trialThe Lancet, 2009
- Recurrence of tuberculosis in a low-incidence settingEuropean Respiratory Journal, 2009
- Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort studyThe Lancet, 2008
- Assessment of New Sterilizing Drugs for Treating Pulmonary Tuberculosis by Culture at 2 MonthsAmerican Review of Respiratory Disease, 1993
- 1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic AgentsJournal of Medicinal Chemistry, 1962
- Über Hydrazinderivate der PyridincarbonsäurenMonatshefte für Chemie / Chemical Monthly, 1912